Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
+8.8%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,810
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$101M |
| 2 |
Eli Lilly
LLY
|
+$99.8M |
| 3 |
Kinder Morgan
KMI
|
+$96.2M |
| 4 |
UnitedHealth
UNH
|
+$75.9M |
| 5 |
Palo Alto Networks
PANW
|
+$65.5M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 3 |
Microsoft
MSFT
|
+$120M |
| 4 |
Charles Schwab
SCHW
|
+$116M |
| 5 |
Bank of America
BAC
|
+$96.7M |
Sector Composition
| 1 | Technology | 22.9% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Hain Celestial
HAIN
$176M
| $1.24M | ﹤0.01% |
72,191
+10,868
| +18% | +$186K |
|
1077
Hillenbrand
HI
$1.75B
| $1.24M | ﹤0.01% |
26,012
+2,050
| +9% | +$97.4K |
|
1078
Ovintiv
OVV
$11B
| $1.23M | ﹤0.01% |
34,120
-320
| -0.9% | -$11.5K |
|
1079
Magna International
MGA
$12.9B
| $1.23M | ﹤0.01% |
22,991
+3,400
| +17% | +$182K |
|
1080
IPG Photonics
IPGP
$3.44B
| $1.23M | ﹤0.01% |
9,970
+1,300
| +15% | +$160K |
|
1081
Lumentum
LITE
$11.5B
| $1.23M | ﹤0.01% |
22,743
+2,550
| +13% | +$138K |
|
1082
Energizer
ENR
$1.94B
| $1.23M | ﹤0.01% |
35,372
-8,059
| -19% | -$280K |
|
1083
Prestige Consumer Healthcare
PBH
$3.2B
| $1.23M | ﹤0.01% |
19,575
+800
| +4% | +$50.1K |
|
1084
Badger Meter
BMI
$5.23B
| $1.22M | ﹤0.01% |
10,052
+1,450
| +17% | +$177K |
|
1085
Merit Medical Systems
MMSI
$5.26B
| $1.22M | ﹤0.01% |
16,490
+400
| +2% | +$29.6K |
|
1086
Diodes
DIOD
$2.44B
| $1.22M | ﹤0.01% |
13,139
+2,340
| +22% | +$217K |
|
1087
Kosmos Energy
KOS
$832M
| $1.22M | ﹤0.01% |
163,800
| – | – |
|
1088
CONMED
CNMD
$1.63B
| $1.21M | ﹤0.01% |
11,660
+700
| +6% | +$72.7K |
|
1089
Grand Canyon Education
LOPE
$5.69B
| $1.21M | ﹤0.01% |
10,630
+950
| +10% | +$108K |
|
1090
Freshpet
FRPT
$2.61B
| $1.21M | ﹤0.01% |
18,280
+962
| +6% | +$63.7K |
|
1091
Ultragenyx Pharmaceutical
RARE
$3.02B
| $1.21M | ﹤0.01% |
30,140
| – | – |
|
1092
Globus Medical
GMED
$7.89B
| $1.21M | ﹤0.01% |
21,292
| – | – |
|
1093
Bank of New York Mellon
BK
$73.3B
| $1.2M | ﹤0.01% |
26,506
+576
| +2% | +$26.2K |
|
1094
Integra LifeSciences
IART
$1.2B
| $1.2M | ﹤0.01% |
20,916
+550
| +3% | +$31.6K |
|
1095
AXIS Capital
AXS
$7.59B
| $1.2M | ﹤0.01% |
21,920
+800
| +4% | +$43.6K |
|
1096
Acadia Pharmaceuticals
ACAD
$4.02B
| $1.2M | ﹤0.01% |
63,500
| – | – |
|
1097
Hanover Insurance
THG
$6.37B
| $1.19M | ﹤0.01% |
9,288
+300
| +3% | +$38.6K |
|
1098
Restaurant Brands International
QSR
$20.3B
| $1.19M | ﹤0.01% |
17,808
| – | – |
|
|
RVNC
1099
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.19M | ﹤0.01% |
37,000
| – | – |
|
1100
Kymera Therapeutics
KYMR
$3.11B
| $1.19M | ﹤0.01% |
40,207
| – | – |
|